Therefore, it is necessary to investigate the correlation and mechanism between the elevated circulating levels of MPN-promoting inflammatory cytokines IL-10, MIG, and RANTES and the common clinical complications of MPN, and to provide the possibility of targeting the above cytokines to alleviate the clinical complications. This evidence concerns the gene CCL5 and myeloproliferative neoplasm.